Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today an

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision o

Gainers Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market

Lantern Pharma Inc. (NASDAQ:LTRN), an AI‑driven precision oncology company transforming the cost, pa

Lantern Pharma (NASDAQ:LTRN) reported second-quarter financial results on Friday. The transcript fro

Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.57) per share which missed the analyst

Lantern Pharma Inc. (Nasdaq: LTRN), a clinical-stage AI-driven precision oncology company, today ann

The study will be conducted at Rigshospitalet in Copenhagen — Denmark’s national referral center for

The United States Patent and Trademark Office has issued Lantern Biopharma a Notice of Allowance for

Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 95.7% to $1.4 during Wednesday's

ZetaOmics introduces an autonomous "Computational Biologist" persona (agent) that performs r

Exon 21 L858R NSCLC Mutated Patients Treated Through Up to Six Cycles Reached 8.9-Month Median PFS;

In its written responses to Lantern's Type C meeting request, the FDA raised no objections to ke

Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.30) per share which beat the analyst c

Lantern Pharma announced that it has entered into a definitive agreement for the purchase and sale o

For the first time, pharmaceutical scientists and medicinal chemists can access a unified, benchmark

The event follows the platform's scientific community debut at the American Association for Canc

Lantern Pharma Schedules Type C Meeting with the FDA to Advance HARMONIC™ Protocol Amendments Target

Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.36) per share which beat the analyst c

Lantern Pharma shares rebound in premarket trading as the company debunks a false report regarding C

PMGC Holdings shares surged 100.6% to $3.35 in pre-market trading after announcing a licensing agree

The Planned Multicenter Phase 1 Trial Will Evaluate STAR-001 as Monotherapy and in Combination with

The A.I. Center of Excellence is planned to be based in Bengaluru and focus on large scale data-engi

Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.39) per share which beat the analyst c

Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

  On Monday, 369 companies set new 52-week lows.